Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $162,251,771    

Indirect Value

   $375,195,594      
Total Shares   71,480,988      
Total Value   $537,447,365      


Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $162,231,150 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    6   
    0    
     Stock price went down :
    8   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   46.5%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-03 4 A $0.00 $0 D/D 20,000 3,450,000 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2013-05-16 4 A $0.00 $0 D/D 20,000 3,470,000 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2013-10-15 4 OE $4.94 $49,400 D/D 10,000 3,480,000 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-05-30 4 B $9.17 $32,095,000 I/I 3,500,000 3,500,000 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2014-05-13 4 A $0.00 $0 D/D 24,876 3,504,876 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2015-05-06 4 A $0.00 $0 D/D 13,175 3,518,051 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-08-08 4 S $17.52 $2,570,499 I/I (146,718) 3,529,470 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2016-05-04 4 A $0.00 $0 D/D 20,202 3,538,253 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2017-05-04 4 A $0.00 $0 D/D 14,135 3,552,388 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2017-05-11 4 OE $10.37 $103,700 D/D 10,000 3,562,388 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-13 4 B $8.74 $574,332 I/I 65,713 3,565,713 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-27 4 S $16.90 $826,866 I/I (48,927) 3,616,655 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-26 4 S $17.30 $2,595,000 I/I (150,000) 3,645,729 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-16 4 B $7.44 $2,566,130 I/I 344,910 3,678,438 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-14 4 B $8.71 $1,112,206 I/I 127,693 3,693,406 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $17.32 $1,799,548 I/I (103,900) 3,734,865 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-29 4 S $16.97 $2,077,654 I/I (122,431) 3,796,606 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-28 4 S $16.99 $2,181,261 I/I (128,385) 3,869,359 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-17 4 B $8.66 $2,061,253 I/I 238,020 3,931,426 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2018-06-27 4 S $17.34 $927,777 I/I (53,505) 3,945,650 0 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-18 4 B $8.87 $137,387 I/I 15,489 3,946,915 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-19 4 B $9.00 $207,765 I/I 23,085 3,970,000 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2012-05-17 4 B $7.50 $2,242,553 I/I 299,007 3,977,445 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-03-18 4 B $4.57 $948,485 I/I 207,546 4,177,546 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2015-12-01 4 GD $0.00 $0 I/I 200 4,856,971 0 -
  271  Records found
  1   2   3   4   5   6   7   8  9   10   11      
  Page 8 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us